斧头财信投行研报 · 机构纪要 · 外媒原文 · 快讯

CSPC Pharmaceutical Group announced that its first mRNA-LNP-…

2026-06-02 18:22 · 快讯 · 斧头财信

CSPC Pharmaceutical Group announced that its first mRNA-LNP-based dual-target CAR-T cell injection has received clinical trial approval in China.

来源：公开资讯　|　整理：斧头财信

最新快讯

📌 斧头财信 每日整理投行研报、机构纪要与外媒原文。微信搜索公众号「斧头财信」，输入 FTKX-GZH-3DAY 即可领取 3 天会员体验。